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Abstract
Objectives—Infants are at high risk of developing chronic, life-threatening disease as a result of 
hepatitis B virus infection. Universal vaccination of infants against hepatitis B virus, before 
discharge from the hospital after delivery is recommended as a measure to eradicate infection and 
associated mortality and morbidity. The purpose of this study was to determine rates of perinatal 
hepatitis B vaccine (Hep B) administration at a tertiary care center in Iowa and to assess the 
impact of maternal factors on Hep B uptake.
Methods—Data concerning mother-infant pairs that received care at one institution from 
1/2009-4/1/2013 were extracted from the system’s electronic medical record. Characteristics of 
study participants were compared using chi-square tests. Multivariate logistic regression was used 
to assess the association between each factor and vaccination status, controlling for other 
characteristics.
Results—Of 5,663 mother-infant pairs, 5,175 (91.4%) infants received Hep B within 7 days after 
delivery. The majority of those not vaccinated had a medical indication to delay vaccination. 
Single women were significantly more likely to have an infant not vaccinated, after adjustment for 
all other factors. Women of minority groups were significantly less likely to have an infant who 
lacked Hep B at hospital discharge than Caucasian women.
Conclusions—Significant improvements have occurred in Hep B rates in the state and region. 
Infants of single mothers may be at the greatest risk for lacking vaccination at hospital discharge.
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The vaccination of newborn infants in the hospital with a hepatitis B vaccine (Hep B) is a 
principal element in The Advisory Committee on Immunization Practices’ (ACIP) strategy 
to eradicate hepatitis B virus (HBV) infection in the United States. The current 
recommendation, since 2005, is that all medically stable infants weighing ≥ 2,000g be 
vaccinated prior to hospital discharge. This recommendation is included in the 2013 
recommended immunization schedule for persons age 0-18, supported also by the American 
Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), and 
the American Congress of Obstetricians and Gynecologists (ACOG) (1).
Acute hepatitis B has the propensity to become a chronic infection and lead to cirrhosis of 
the liver and hepatocellular carcinoma (HCC). Infants, are at especially high risk; 90% or 
greater of those infected will develop chronic disease (2, 3). Infants are most likely to 
become infected by vertical transmission from the mother at the time of delivery or by 
horizontal transmission from any infected person, usually a person living in the home and/or 
coming into frequent contact with the infant (2, 3). Screening of all pregnant women for 
HBV infection (HbsAg-positive) is recommended. Prophylactic treatment with hepatitis B 
immune globulin (HBIG) is indicated for infants born to HbsAg-positive women and 
women whose HBV status is unknown. The administration of Hep B to all infants prior to 
discharge provides a secondary method of prevention for those infants who are not identified 
by the maternal screening process and protection from other contacts in the first weeks of 
life (1-4). Studies have found completion of a 3 or 4-dose schedule of Hep B vaccination 
without administration of HBIG ≤ 12 hours after delivery prevents 70% – 95% of HBV 
infections among infants whose mothers are infected (3). Additionally, administration of the 
first dose of Hep B after delivery, prior to discharge, has been shown to be associated with 
the completion of the recommended Hep B series during childhood (5).
The incidence of HBV in persons < 15 years of age decreased by 98%, from 1.2 cases per 
100,000 in 1990 to 0.02 cases per 100,000 in 2007 (6). However, there remains room for 
improvement as perinatal HBV infections persist in the US. Reports by the CDC conclude 
that complete elimination of HBV will require improved preventive practices (2, 7). Thus, 
particularly in an era in which it is not uncommon for parents to refuse or delay vaccination 
for their children (8, 9), it is crucial to continue to monitor Hep B rates. The National 
Immunization Survey (NIS) estimated that, between 2003 and 2005, only 23.1% of infants 
born in Iowa were vaccinated with Hep B by day 3 of life, substantially lower than the 
national average of 50.1% during the same period (4). The primary purpose of this study 
was to identify maternal factors associated with lack of Hep B prior to hospital discharge 
after birth at a tertiary care center in the state of Iowa. This study also sought to determine 
current rates of perinatal Hep B administration to assess whether rates have increased since 
2005.
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The University of Iowa Hospitals and Clinics (UIHC) is a tertiary referral center that 
performs high-risk deliveries and has a level IV neonatal intensive care unit (NICU). To 
collect data, programming was developed through collaboration with the Institute for 
Clinical and Translational Science (ICTS) at the University of Iowa that allowed review of 
de-identified, linked mother-baby records. Data was extracted from the records of every 
mother-baby pair in which the woman delivered at the UIHC from January 1, 2009 – April 
1, 2013. Inclusion criteria required that the mother had at least one in-person encounter at 
one of 13 selected departments providing prenatal care within this healthcare system in the 
nine months prior to delivery.
Information extracted from the mother’s patient records included: the mother’s age, marital 
status, race, ethnicity, and insurance provider, all at the time of data extraction. Hep B 
vaccination - administration of the Hep B within 7 days of birth and prior to hospital 
discharge - was obtained from the infant’s hospital admission record. Although most infants 
are discharged by the third day of life - and thus would receive vaccination by DOL 3 as is 
recommended, because of the high acuity of many patients who deliver at this institution, 
data was collected on vaccination up to day of life (DOL) 7 to account for infants who had a 
slightly extended hospital stay and would have, appropriately, had vaccination later. Infants 
who got the vaccination on DOL 7 but as an outpatient were not considered compliant with 
ACIP recommendations. At the institution in question, in the absence of parental refusal, 
infants receive Hep B on DOL 60 or prior to discharge, whichever occurs first. Under 
circumstances when the mother’s HBV status is unknown, vaccination may be done as soon 
as possible once the infant is stabilized. Maternal data reported are from the time the data 
was extracted rather than date of delivery, thus some data may have changed slightly in the 
1-3 year interval. This predominately affects maternal age data. This was necessary because 
in order to perform an anonymous data extraction, the date of delivery and the mother’s date 
of birth could not be known to investigators. Due to the large sample size of this study and 
the broad categories used for age group, marital status, and insurance type, this affects 
relatively few data sets and impact on the study was deemed to be minimal. A subsequent 
extraction and analysis were later performed, which did assess for impact of the date of 
delivery and proximity of the families residence to the hospital in question.
An electronic medical record review of 100 randomly selected mother-infant pairs in which 
the infant did not receive Hep B by DOL 7 and 100 randomly selected pairs in which the 
infant did receive Hep B by DOL 7 assessed for variables related to the infant’s health and 
disposition at the time of birth and DOL 7. The Institutional Review Board (IRB) of the 
University of Iowa Human Subjects Office approved all components of data extraction and 
analysis involved in this study (IRB # 201311711).
Statistical Analysis
Characteristics of the study participants were compared according to Hep B status (yes/no) 
using chi-square tests. Univariate logistic regression was used to assess the association 
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between each demographic factor (maternal age, maternal race, maternal ethnicity, marital 
status, and type of health insurance) and vaccination status. Additionally, multivariate 
logistic regression was conducted for each of the demographic factors, controlling for the 
other four factors. All analyses were performed using SAS 9.3 (SAS Institute, Cary, NC, 
USA).
Results
A total of 5,663 mother-newborn pairs were included in this study. Characteristics of the 
study population are shown in Table 1. A total of 5,175 (91.4%) infants received Hep B 
prior to discharge and by DOL 7. The proportion of women whose infants received Hep B 
was similar across all maternal age groups. Caucasian and African-American women were 
the least likely to have infants who were vaccinated (90.5%) whereas Asian women were the 
most likely to have infants vaccinated (96.3%). Additionally, married women (92.7%) and 
those with employer or school-based health insurance (92.3%) were most likely to have an 
infant that received Hep B after birth. Results of the unadjusted and adjusted logistic 
regression analyses are presented in Table 2. Single women were significantly more likely to 
have an infant not vaccinated in the hospital after adjustment for age, race, ethnicity, and 
health insurance provider (aOR 1.72, 95% CI 1.35, 2.19) when compared to married women. 
No significant association was observed for maternal age or health insurance provider.
Secondary extraction and analyses showed that infants born to women with a primary 
residence greater than 20 miles from the institution in question or outside of the state were 
significantly more likely to lack vaccination within 7 days of life (aOR of 3.21, 95% CI 
2.55, 4.03 and 2.63, 95% CI 1.71, 4.04 respectively). This group may have delivered at this 
institution due to a high-risk status and have infants who were more likely to spend greater 
than 7 days in the hospital’s NICU, which does not vaccinate for Hep B until infants are 
stable and shortly before discharge and so this extraction did not identify them as receiving 
the vaccine. A randomized electronic record review of 200 mother-infant pairs (100 in 
which the infant received Hep B by DOL 7 and 100 in which the infant did not receive Hep 
B by DOL 7) revealed that 74% (95% CI 66.6,81.7) of those infants who did not receive 
Hep B by DOL 7, compared to 13% (95% CI 6.5, 18.5) of those infants that did receive Hep 
B by DOL 7, were either admitted or were deceased (4 infants) on the 7th day after delivery. 
Of the 70 infants who were inpatient, 1 infant remained in the mother-baby care unit while 
the other 69 were admitted to intensive care units.
The majority of infants admitted to intensive care units at this institution would not be 
considered stable enough to receive vaccination and/or would not meet the weight 
requirement of 2000g. These infants represent a group for which delay of vaccination would 
be indicated rather than due to parental decision or provider’s preference to delay 
vaccination. By extrapolating these results to the larger study population one can estimate 
that of the 488 infants to lack Hep B on DOL 7, 361 (74%) had a medical indication to delay 
vaccination and 127 infants (26%), or 2.24% of the total study population did not receive 
vaccination when it was medically indicated.
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The relationship between maternal marital status and infant disposition (admission to the 
hospital vs. discharge) on DOL 7 was examined among the 200 patient sample used for 
electronic medical record review. Among all 200 infants, the odds of an infant that was 
admitted (or deceased) 7 days after delivery also having a single mother was 2.78 (p = 
0.002). Among those infants who did not receive Hep B by DOL 7, the odds of an infant that 
was admitted having a single mother was 4.79 (p = 0.008). There was no significant 
association between infants’ disposition on DOL 7 and marital status among those infants 
that had received Hep B, OR 0.32 (p = 0.289).
Discussion
Overall Hep B Vaccination Rates
During the period from January 1, 2009 – April 1, 2013, a significant majority (91.4%) of 
newborns born at a Midwestern tertiary care center received the Hep B within 7 days after 
birth and prior to hospital discharge. Data suggests that 26% of those not vaccinated, or 
2.24% of the entire study population, did not get vaccination in the setting of medical 
indication. The NIS found that of births 2003 – 2005, 42.8% and 52.5% of infants were 
vaccinated by day 1 and day 6 of life, respectively (4). However, in Iowa only 20.2% and 
23.1% of infants were vaccinated by day 1 and day 3 respectively (4). Findings of the 
present study suggest that in-hospital Hep B rates within the state have increased 
dramatically. As shown in Figure 1, during the 2003-2005 study period, the incidence of 
acute, symptomatic hepatitis B in Iowa ranged from 0.6 – 1.1 cases per 100,000 population 
(average of 0.8 per 100,000). From 2009-2012, the incidence ranged from 1.2 (a ten-year 
high in 2009) to 0.4 cases per 100,000 population (average of 0.65). Though data is not 
sufficient to prove a correlation between vaccination rates of infants and disease incidence, 
this does demonstrate at positive association over time. Unfortunately data from 2013 and 
prevalence rates from the CDC were not available. It is important to consider also that the 
CDC estimates the actual number of acute cases of hepatitis B to be 6.5 times the number of 
reported cases (10).
In 1999, in response to concerns raised by the US Food and Drug Administration (FDA) 
regarding the presence of the thimerosal and ethyl mercury in the vaccine, the AAP and the 
US Public Health Service (USPHS) issued a joint statement recommending healthcare 
providers postpone the birth-dose of Hep B. Within the same year, Hep B without 
thimerosal was available and the recommendation to postpone vaccination was lifted. An 
analysis of data from the NIS found that reductions in vaccination at birth persisted after this 
period (11). The findings of the present study suggest that hospitals and parents in Iowa 
were slow to return to vaccination at birth, but rates have now increased beyond the latest 
national estimates (4, 12).
To explain why 13% of those that did get Hep B vaccination in the electronic medical record 
review were still admitted on DOL 7, one probable explanation is that, though admitted, 
they were admitted to a low acuity neonatal intensive care unit and vaccination occurred as 
part of the preparation for discharge, as per NICU practices.
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Impact of Maternal Marital Status
The odds that infants born to single women will lack Hep B upon hospital discharge were 
found to be nearly twice that of infants born to married women, after controlling for all other 
factors, including insurance provider. To the authors’ knowledge, this finding has not been 
previously documented. Repeated studies have documented an increased risk of preterm 
birth among single women (13). Single women referred to this institution for prenatal care 
and delivery may be more likely to have infants for whom it is medically indicated to delay 
vaccination with Hep B beyond the first week of life. The inclusion criteria that women in 
the study have had at least one prenatal visit at this institution limited the impact of this 
cofounding issue by excluding all those who were transferred only for impending preterm 
labor.
Why single women were less likely to have infants vaccinated with Hep B in the hospital 
remains unclear. Analysis of the electronic medical record review suggests that this 
observation can be partially explained by the phenomenon that single women are also more 
likely to deliver an infant that requires inpatient treatment for greater than 7 days. However, 
there may be other reasons single women are more likely to have unvaccinated infants also. 
As has been proposed an explanation for the higher risk of preterm birth among single 
women, these women may lack some of the social and emotional support of married women 
(13). The postpartum time is generally acknowledged as an overwhelming and stressful time 
for all parents. Single women in particular may struggle with the burden of yet another 
decision to make while they are in the hospital and, without a partner for emotional support, 
may lack confidence in their decisions. Therefore, single women may choose to defer 
vaccination until a later time.
Impact of Mothers’ Race & Ethnicity
Women who identified as Hispanic, Asian, or another racial group were significantly more 
likely than Caucasians to have infants that were vaccinated prior to discharge. No significant 
difference was found between African-Americans and Caucasians. The majority of past 
studies have found no significant impact of maternal race and ethnicity on likelihood of 
children’s Hep B or overall vaccination status (12, 14, 15). Caucasian women in this 
population may perceive their infants to be at low risk of coming into contact with the virus 
early during infancy. Likewise, it is possible that providers also view Caucasian women and 
their infants as low-risk and are, therefore, less insistent on the importance of vaccination for 
newborns. Women who are of a minority group (this population was 74% Caucasian) may 
perceive their own environments to convey a greater risk to the newborn or providers may 
perceive it as such. This theory is supported by the fact that infants with Asian mothers were 
the most likely to be vaccinated and those of Asian ancestry are documented to be at a 
greater risk for HBV exposure (16, 17).
Impact of Maternal Insurance Status
Importantly, no significant impact of presence or lack of health insurance or type of 
insurance was observed. Willis et al (12), who performed a nation-wide study, found that the 
most significant predictors of newborn vaccination were residence in a state with a policy to 
provide the newborn Hep B at no cost for those without insurance and delivery at a hospital 
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with a written policy for universal Hep B vaccination at birth. The state of Iowa participates 
in the Vaccines for Children (VFC) program (a federal program that provides free 
vaccinations to children who are uninsured, underinsured, insured by Medicaid or American 
Indian or Alaska Native (18).
Impact of Maternal Age
The effect of maternal age on likelihood of infant Hep B was not found to be significant 
after controlling for other factors. Past studies have documented similar findings (11, 12). 
Education and income are cofounders for the impact of maternal age but the VFC program 
largely negates the impact of income. This may partially explain the lack of effect of 
maternal age observed.
Study Strengths and Limitations
Adding to the strength of this study is its large sample size. However, there are some 
important differences between the study population the rest of the state, which could hamper 
the study’s generalizability. In 2011, 87% of births in Iowa were among Caucasian women, 
while 74% in the women in the present study population were Caucasian. Supplemental 
Table 1 provides natality data from the state during the period of study. Though a limitation 
in the sense of generalizability, this is a strength in that it was possible to assess the Hep B 
rate in minority groups that are underrepresented in other hospitals across the state. The 
study site is a major tertiary care center for Eastern Iowa, and, therefore, women 
experiencing high-risk pregnancies or pregnancy complications, for which African-
American’s are more susceptible, are referred to the hospital of study. Likewise, the study 
institution is located alongside a large undergraduate and graduate university. Thus, the local 
population is more urban and more diverse in terms of both race and socioeconomic status 
than the majority of the state.
Additionally, the present study did not assess for the influence of maternal education and 
data was not collected on which mothers were screened for HBV during pregnancy. Women 
who were screened and tested negative might have chosen to not vaccinate their infant, as 
their perceived threat was low.
Conclusions
A majority of infants born at a tertiary care center in Iowa are receiving Hep B within 7 days 
after birth and prior to discharge from the hospital. Most vaccinations likely occur within the 
first or second day of life as most healthy infants rarely remain in the hospital beyond this 
time. This study has documented substantial and important improvements in vaccination 
rates in this region from less than a decade previously (4). In order to eliminate HBV, 
universal vaccination must remain the goal. Providers need to remain vigilant of vaccine 
uptake, particularly for infants of single mothers. For families who may perceive their 
newborns to be at low risk, education on the resilience of the virus in the environment and 
the severity of illness among newborns may make a meaningful impact. Also, education for 
providers on the risks of perinatal HBV infection and the evidence supporting vaccination at 
birth should remain a priority of public health and training programs. Future research in this 
Myers et al. Page 7













area should investigate how perceptions of risk impact parents’ and providers’ decisions 
about vaccines. Additionally, surveillance of vaccine uptake in more rural parts of the state 
and region are important to insure that professional guidelines are followed outside of large 
teaching hospitals and healthcare systems such as the one involved in this study.
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Refer to Web version on PubMed Central for supplementary material.
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Data adapted from incidence reports of the Centers for Disease Control and Prevention Viral 
Hepatitis Statistics & Surveillance Program.
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Table 2
Odds of Infants Born within the University of Iowa Hospitals and Clinics healthcare system not receiving 
Hepatitis B Vaccination Prior to Hospital Discharge
N Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)a
Maternal Age Group
 15-20 149 1.00 (Ref) 1.00 (Ref)
 21-30 2394 0.57 (0.35 - 0.93) 0.67 (0.41 - 1.10)
 31-40 2796 0.54 (0.34 - 0.88) 0.75 (0.45 - 1.26)
 41-53 324 0.69 (0.39 - 1.24) 0.94 (0.51 - 1.75)
Marital Status
 Married 4016 1.00 (Ref) 1.00 (Ref)
 Single 1413 1.75 (1.43 - 2.13) 1.72 (1.35 - 2.19)
 Other 234 1.24 (0.78 - 1.98) 1.25 (0.78 - 2.02)
Race
 Caucasian 4189 1.00 (Ref) 1.00 (Ref)
 African-American 388 1.00 (0.70 - 1.42) 0.78 (0.53 - 1.13)
 Hispanic 409 0.46 (0.29 - 0.74) 0.29 (0.14 - 0.61)
 Asian 377 0.37 (0.21 - 0.63) 0.41 (0.24 - 0.71)
 Other 300 0.61 (0.37 - 0.98) 0.40 (0.24 - 0.67)
Ethnicity
 Non-Hispanic 4398 1.00 (Ref) 1.00 (Ref)
 Hispanic 336 0.60 (0.37 - 0.99) 1.55 (0.69 - 3.46)
 Unknown 929 1.58 (1.27 - 1.98) 1.84 (1.45 - 2.35)
Health Insurance
 Employer/School Based 2517 1.00 (Ref) 1.00 (Ref)
 State Assisted/VA 817 1.48 (1.14 - 1.93) 1.11 (0.82 - 1.49)
 None/Not on File 2329 1.15 (0.94 - 1.41) 0.99 (0.80 - 1.24)
Univariate and multivariate regression models are modelling the outcome of no vaccination
a
Models adjusted for all other demographics in this table
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